These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 29077856

  • 1. The clinical implications of mean platelet volume and mean platelet volume/platelet count ratio in locally advanced esophageal squamous cell carcinoma.
    Sun SY, Zhao BQ, Wang J, Mo ZX, Zhao YN, Wang Y, He J.
    Dis Esophagus; 2018 Feb 01; 31(2):. PubMed ID: 29077856
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
    Ji WH, Jiang YH, Ji YL, Li B, Mao WM.
    Dis Esophagus; 2016 Jul 01; 29(5):403-11. PubMed ID: 25625421
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
    Ning ZH, Zhao W, Li XD, Chen LJ, Xu B, Gu WD, Shao YJ, Xu Y, Huang J, Pei HL, Jiang JT.
    Int J Clin Exp Pathol; 2015 Jul 01; 8(6):6881-90. PubMed ID: 26261575
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of hematological parameters in patients undergoing esophagectomy for esophageal squamous cell carcinoma.
    Hirahara N, Matsubara T, Kawahara D, Mizota Y, Ishibashi S, Tajima Y.
    Int J Clin Oncol; 2016 Oct 01; 21(5):909-919. PubMed ID: 27154178
    [Abstract] [Full Text] [Related]

  • 9. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
    Duan H, Zhang X, Wang FX, Cai MY, Ma GW, Yang H, Fu JH, Tan ZH, Meng YQ, Fu XY, Ma QL, Lin P.
    World J Gastroenterol; 2015 May 14; 21(18):5591-7. PubMed ID: 25987784
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancer.
    Inagaki N, Kibata K, Tamaki T, Shimizu T, Nomura S.
    Lung Cancer; 2014 Jan 14; 83(1):97-101. PubMed ID: 24189108
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Preoperative NLR and PLR in the middle or lower ESCC patients with radical operation.
    He YF, Luo HQ, Wang W, Chen J, Yao YW, Yan Y, Wu SS, Hu XX, Ke LH, Niu JY, Li HM, Ji CS, Hu B.
    Eur J Cancer Care (Engl); 2017 Mar 14; 26(2):. PubMed ID: 26947428
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer.
    Xie X, Luo KJ, Hu Y, Wang JY, Chen J.
    Dis Esophagus; 2016 Jan 14; 29(1):79-85. PubMed ID: 25410116
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diagnostic and prognostic role of mean platelet volume and mean platelet volume/platelet ratio in patients with primary malignant bone tumor.
    Sökmen FC, Ulucaköy C.
    Jt Dis Relat Surg; 2021 Jan 14; 32(1):198-203. PubMed ID: 33463437
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of pre-operative serum uric acid levels in esophageal squamous cell carcinoma patients who undergo R0 esophagectomy.
    Chen YF, Li Q, Chen DT, Pan JH, Chen YH, Wen ZS, Zeng WA.
    Cancer Biomark; 2016 Jun 07; 17(1):89-96. PubMed ID: 27314297
    [Abstract] [Full Text] [Related]

  • 20. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S, Tsubosa Y, Sato H, Takebayashi K, Kawamorita K, Mori K, Niihara M, Tsushima T, Yokota T, Onozawa Y, Yasui H, Takeuchi H, Kitagawa Y.
    Dis Esophagus; 2017 Feb 01; 30(2):1-8. PubMed ID: 26919154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.